Setting Strategic Objectives for the Coalition for Epidemic Preparedness Innovations: An Exploratory Decision Analysis Process

References

• Abuabara L, Paucar-Caceres A, Belderrain MCN, Burrowes-Cromwell T (2017) A systematic framework based on soft OR approaches to support teamwork strategy: An aviation manufacturer Brazilian company case. J. Oper. Res. Soc. 69(2):220–234.Google Scholar
• Ackermann F, Eden C (2011) Strategic management of stakeholders: Theory and practice. Long Range Planning 44(3):179–196.Google Scholar
• Ackermann F, Belton V, Ensslin L, Montibeller G (2007) Reasoning maps for decision aid: An integrated approach for problem-structuring and multi-criteria evaluation. J. Oper. Res. Soc. 59(5):575–589.Google Scholar
• Ackoff RL (1974) Redesigning the Future: A Systems Approach to Societal Problems (John Wiley & Sons, New York).Google Scholar
• Ali S, Ronaldson S (2012) Ordinal preference elicitation methods in health economics and health services research: Using discrete choice experiments and ranking methods. British Medical Bull. 103(1):21–44.Google Scholar
• Angelis A, Kanavos P (2017) Multiple criteria decision analysis (MCDA) for evaluating new medicines in health technology assessment and beyond: The advance value framework. Soc. Sci. Medicine 188(September):137–156.Google Scholar
• Arvai JL, Gregory R, McDaniels TL (2001) Testing a structured decision approach: Value-focused thinking for deliberative risk communication. Risk Anal. 21(6):1065–1076.Google Scholar
• Baltussen R, Stolk E, Chisholm D, Aikins M (2006) Toward a multi-criteria approach for priority setting: An application to Ghana. Health Econom. 15(7):689–696.Google Scholar
• Bana e Costa CA, Ensslin L, Corria EC, Vansnick JC (1999) Decision support systems in action: Integrated application in a multi-criteria decision aid process. Eur. J. Oper. Res. 113(2):315–335.Google Scholar
• Becker RA, Eick SG, Wilks AR (1995) Visualizing network data. IEEE Trans. Visualization Comput. Graphics 1(1):16–28.Google Scholar
• Belton V, Stewart T (2002) Multiple Criteria Decision Analysis: An Integrated Approach (Springer Science & Business Media, Dordrecht, Netherlands).Google Scholar
• Belton V, Steward T (2010) Problem structuring and MCDA. Ehrgott M, Figueira JR, Greco S, eds. Trends in Multiple Criteria Decision Analysis (Springer, New York), 209–239.Google Scholar
• Belton V, Ackermann F, Shepherd I (1997) Integrated support from problem structuring through to alternative evaluation using COPE and VISA. J. Multi-Criteria Decision Anal. 6(3):115–130.Google Scholar
• Bill & Melinda Gates Foundation (2018) Culture & values. Accessed May 14, 2019, https://www.gatesfoundation.org/Careers/Culture-and-Values.Google Scholar
• Boddie C (2015) Federal funding in support of Ebola medical countermeasures R&D. Health Security 13(1):3–8.Google Scholar
• Boddie C, Sell TK, Watson M (2014) Federal funding for health security in FY2015. Biosecurity Bioterrorism 12(4):163–177.Google Scholar
• Brende B, Farrar J, Gashumba D, Moedas C, Mundel T, Shiozaki Y, Vardhan H, Wanka J, Røttingen JA (2017) CEPI—A new global R&D organisation for epidemic preparedness and response. Lancet 389(10066):233–235.Google Scholar
• Bridges JF, Gallego G, Kudo M, Okita K, Han KH, Ye SL, Blauvelt BM (2011a) Identifying and prioritizing strategies for comprehensive liver cancer control in Asia. BMC Health Services Res. 11(November):298.Google Scholar
• Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, Johnson FR, Mauskopf J (2011b) Conjoint analysis applications in health—A checklist: A report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health 14(4):403–413.Google Scholar
• Bryson JM (2018) Strategic Planning for Public and Nonprofit Organizations: A Guide to Strengthening and Sustaining Organizational Achievement, 5th ed. (John Wiley & Sons, San Francisco).Google Scholar
• Bryson JM, Ackermann F, Eden C, Finn CB (2004) Visible Thinking: Unlocking Causal Mapping for Practical Business Results (John Wiley & Sons, Chichester, UK).Google Scholar
• Bullock RK, Deckro RF, Weir JD (2008) Methodology for competitive strategy development. Comput. Oper. Res. 35(6):1865–1873.Google Scholar
• Castillo-Chavez C, Curtiss R, Daszak P, Levin SA, Patterson-Lomba O, Perrings C, Poste G, Towers S (2015) Beyond Ebola: Lessons to mitigate future pandemics. Lancet Global Health 3(7):e354–e355.Google Scholar
• Center for Infectious Disease Research and Policy (2015) Recommendations for accelerating the development of Ebola vaccines. Retrieved May 14, 2019, http://www.cidrap.umn.edu/recommendations-accelerating-development-ebola-vaccines-0.Google Scholar
• Christodoulou M (2019) CEPI launches call for proposals to develop vaccines against Rift Valley fever and Chikungunya viruses. Accessed May 14, 2019, https://cepi.net/news_cepi/cepi-launches-call-for-proposals-to-develop-vaccines-against-rift-valley-fever-and-chikungunya-viruses/.Google Scholar
• Coalition for Epidemic Preparedness Innovations (2016) CEPI—Preliminary business plan 2017–2021. Report, Coalition for Epidemic Preparedness Innovations, Oslo, Norway.Google Scholar
• Coalition for Epidemic Preparedness Innovations (2017) Call for proposals. Retrieved May 14, 2019, http://cepi.net/CfP.Google Scholar
• Coalition for Epidemic Preparedness Innovations (2018) Calls for proposals. Retrieved May 14, 2019, http://cepi.net/calls.Google Scholar
• Cohen J, Kupferschmidt K (2014) Ebola vaccine trials raise ethical issues. Science 346(6207):289–290.Google Scholar
• de Bekker-Grob EW, Ryan M, Gerard K (2012) Discrete choice experiments in health economics: A review of the literature. Health Econom. 21(2):145–172.Google Scholar
• de Bekker-Grob EW, Donkers B, Jonker MF, Stolk EA (2015) Sample size requirements for discrete-choice experiments in healthcare: A practical guide. Patient 8(5):373–384.Google Scholar
• Drugs for Neglected Diseases Initiative (2009) Access policy. Retrieved May 14, 2019, https://www.dndi.org/wp-content/uploads/2018/03/DNDi_Access_Policy.pdf.Google Scholar
• Eden C (2004) Analyzing cognitive maps to help structure issues or problems. Eur. J. Oper. Res. 159(3):673–686.Google Scholar
• Eden C, Ackermann F (1998) Making Strategy: The Journey of Strategic Management (Sage Publications, London).Google Scholar
• Eden C, Ackermann F (2013) Problem structuring: On the nature of, and reaching agreement about, goals. EURO J. Decision Processes 1(1–2):7–28.Google Scholar
• Ensslin L, Montibeller G, Lima MVA (2000) Constructing and implementing a DSS to help evaluate perceived risk of accounts receivable. Haimes YY, Steuer RE, eds. Research and Practice in Multiple Criteria Decision Making (Springer, Berlin), 248–259.Google Scholar
• Firth D (1993) Bias reduction of maximum likelihood estimates. Biometrika 80(1):27–38.Google Scholar
• Francis JJ (2010) What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psych. Health 25(10):1229–1245.Google Scholar
• Franco LA, Montibeller G (2011) Problem structuring for multicriteria decision analysis interventions. Cochran JJ, Cox LA, Keskinocak P, Kharoufeh JP, Smith JC, eds. Wiley Encyclopedia of Operations Research and Management Science (John Wiley & Sons, Hoboken, NJ).Google Scholar
• Franken M, Koolman X (2013) Health system goals: A discrete choice experiment to obtain societal valuations. Health Policy 112(1–2):28–34.Google Scholar
• Fuerst T, Wallace K, Gomez P, Gambale P, Baird A, Thomas S (2009) Ensuring biologics advanced development and manufacturing capability for the United States government: A summary of key findings and conclusions. Retrieved May 14, 2019, https://apps.dtic.mil/dtic/tr/fulltext/u2/a506569.pdf.Google Scholar
• Gilfillan L, Smith BT, Inglesby TV, Kodukula K, Schuler A, Lister M, O’Toole T (2004) Taking the measure of countermeasures: Leaders’ views on the nation’s capacity to develop biodefense countermeasures. Biosecurity Bioterrorism 2(4):320–327.Google Scholar
• Ginter PM, Duncan WJ, Swayne LE (2013) Strategic Management of HealthCare Organizations, 7th ed. (John Wiley & Sons, San Francisco).Google Scholar
• Global Alliance for Vaccines and Immunisation (2014) Gavi commits to purchasing Ebola vaccine for affected countries. Retrieved May 14, 2019, http://www.gavi.org/library/news/press-releases/2014/gavi-commits-to-purchasing-ebola-vaccine-for-affected-countries/.Google Scholar
• Global Alliance for Vaccines and Immunisation (2018) Gavi’s strategy. Retrieved May 14, 2019, http://www.gavi.org/about/strategy/.Google Scholar
• Gouglas D, Marsh K (2019) Prioritizing investments in new vaccines against epidemic infectious diseases: a multi-criteria decision analysis. J. Multi-Criteria Decision Anal. 26(3–4):153–163.Google Scholar
• Gouglas D, Christodoulou M, Plotkin S, Hatchett R (2019) CEPI: Driving progress toward epidemic preparedness and response. Retrieved July 11, 2019, https://www.uniteforsight.org/conference/ppt-2019/Dimitrios%20Gouglas%20PDF.pdf.Google Scholar
• Gouglas D, Le TT, Henderson K, Kaloudis A, Danielsen T, Hammersland NC, Robinson JM, Heaton PM, Røttingen JA (2018) Estimating the cost of vaccine development against epidemic infectious diseases: A cost minimisation study. Lancet Global Health 6(12):Pe1386–Pe1396.Google Scholar
• Grepin K, Pinkstaff CB, Hole AR, Henderson K, Norheim OF, Røttingen JA, Ottersen T (2018) Allocating external financing for health: A discrete choice experiment of stakeholder preferences. Health Policy Planning 33(Suppl 1):i24–i30.Google Scholar
• Gronvall GK, Matheny J, Smith BT, Mair M, Chamberlain AT, Deitch S, Borio L, Inglesby TV, O’Toole T (2007) Flexible defenses roundtable meeting: Promoting the strategic innovation of medical countermeasures. Biosecurity Bioterrorism 5(3):271–277.Google Scholar
• Hafer N, Maidment BW, Hatchett RJ (2010) The NIAID Radiation Countermeasures Program business model. Biosecurity Bioterrorism 8(4):357–363.Google Scholar
• Hall J, Viney R, Haas M, Louviere JJ (2004) Using stated preference discrete choice modelling to evaluate healthcare programs. J. Bus. Res. 57(9):1026–1032.Google Scholar
• Hauber AB, González JM, Groothuis-Oudshoorn CM, Prior T, Marshall DA, IJzerman MJ, Bridges JF (2016) Statistical methods for the analysis of discrete choice experiments: A report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health 19(4):300–315.Google Scholar
• Helter TM, Boehler CEH (2016) Developing attributes for discrete choice experiments in health: A systematic literature review and case study of alcohol misuse interventions. J. Substance Use 21(6):662–668.Google Scholar
• Howard RA (1988) Decision analysis: Practice and promise. Management Sci. 34(6):679–695.Link, Google Scholar
• Hoyt K, Hatchett R (2016) Preparing for the next Zika. Nature Biotech. 34(4):384–386.Google Scholar
• Institute of Medicine (2010) The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary (National Academies Press, Washington, DC).Google Scholar
• International Crisis Group (2015) The politics behind the Ebola crisis. Report 232, International Crisis Group, Brussels.Google Scholar
• Johnson FR, Lancsar E, Marshall D, Kilambi V, Muhlbacher A, Regier DA, Bresnahan BW, Kanninen B, Bridges JFP (2013) Constructing experimental designs for discrete-choice experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health 16(1):3–13.Google Scholar
• Johnson R, Orme B (2003) Getting the most from CBC. Report, Sawtooth Software, Sequim, WA.Google Scholar
• Kamal-Yanni M (2015) Never again: Building resilient health systems and learning from the Ebola crisis. Retrieved May 14, 2019, https://www.oxfam.org/en/research/never-again-building-resilient-health-systems-and-learning-ebola-crisis.Google Scholar
• Keeney RL (1992) Value-focused Thinking: A Path to Creative Decision Making (Harvard University Press, Cambridge, MA).Google Scholar
• Keeney RL (1994) Using values in operations research. Oper. Res. 42(5):793–813.Link, Google Scholar
• Keeney RL (1996) Value-focused thinking: Identifying decision opportunities and creating alternatives. Eur. J. Oper. Res. 92(3):537–549.Google Scholar
• Keeney RL (2008) Applying value-focused thinking. Military Oper. Res. 13(2):7–17.Google Scholar
• Keeney RL, McDaniels T (1992) Value-focused thinking about strategic decisions at BC Hydro. Interfaces 22(6):94–109.Link, Google Scholar
• Kelly MP, Heath I, Howick J, Greenhalgh T (2015) The importance of values in evidence-based medicine. BMC Medical Ethics 16(1):69.Google Scholar
• Kieny MP, Røttingen JA, Farrar J (2016) The need for global R&D coordination for infectious diseases with epidemic potential. Lancet 388(10043):460–461.Google Scholar
• Knobler S, Mahmoud A, Lemon S, Mack A, Sivitz L, Oberholtzer K (2004) Learning from SARS: Preparing for the Next Disease Outbreak: Workshop Summary (National Academies Press Washington, DC).Google Scholar
• Kristensen F (2016) CEPI: New vaccines for a safer world. Retrieved August 8, 2019, https://www.imi.europa.eu/sites/default/files/uploads/documents/news-events/events/2016/biopreparedness_roettingen_CEPI_new_vaccines_for_safer_world.pdf.Google Scholar
• Kunz RE, Siebert J, Mutterlein J (2016) Combining value-focused thinking and balanced scorecard to improve decision-making in strategic management. J. Multi-Criteria Decision Anal. 23(5–6):225–241.Google Scholar
• Lagarde M, Blaauw D (2009) A review of the application and contribution of discrete choice experiments to inform human resources policy interventions. Human Resources Health 7(July):62.Google Scholar
• Lancsar E, Louviere J (2008) Conducting discrete choice experiments to inform healthcare decision making. Pharmacoeconomics 26(8):661–677.Google Scholar
• Leon OG (1999) Value-focused thinking vs. alternative-focused thinking: Effects on generation of objectives. Organ. Behav. Human Decision Processes 80(3):213–227.Google Scholar
• Lucey DR, Gostin LO (2016) The emerging Zika pandemic: Enhancing preparedness. JAMA 315(9):865–866.Google Scholar
• Maher C, Primmer JH, MacGill T, Courtney B, Borio L (2012) Meeting the challenges of medical countermeasure development. Microbial Biotech. 5(5):588–593.Google Scholar
• Mangham LJ, Hanson K, McPake B (2009) How to do (or not to do)…Designing a discrete choice experiment for application in a low-income country. Health Policy Planning 24(2):151–158.Google Scholar
• Marsh K, Dolan P, Kempster J, Lugon M (2012) Prioritizing investments in public health: A multi-criteria decision analysis. J. Public Health 35(3):460–466.Google Scholar
• Marsh K, Ijzerman M, Thokala P, Baltussen R, Boysen M, Kalo Z, Lonngren T, et al.. (2016) Multiple criteria decision analysis for healthcare decision making—Emerging good practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health 19(2):125–137.Google Scholar
• Marttunen M, Lienert J, Belton V (2017) Structuring problems for multi-criteria decision analysis in practice: A literature review of method combinations. Eur. J. Oper. Res. 263(1):1–17.Google Scholar
• Mason M (2010) Sample size and saturation in PhD studies using qualitative interviews. Forum: Qualitative Soc. Res. 11(3):8.Google Scholar
• Mason RO, Mitroff II (1981) Challenging Strategic Planning Assumptions (John Wiley & Sons, New York).Google Scholar
• McDaniels T, Trousdale W (1999) Value-focused thinking in a difficult context: Planning tourism for Guimaras, Philippines. Interfaces 29(4):58–70.Link, Google Scholar
• McFadden D (1974) Conditional logit analysis of qualitative choice behavior. Zarembka P, ed. Frontiers in Econometrics (Academic Press, New York), 105–142.Google Scholar
• McMillan C, Overall J (2016) Wicked problems: Turning strategic management upside down. J. Bus. Strategy 37(1):34–43.Google Scholar
• Medicines for Malaria Venture (2017) MMV strategic focus 2017–2021: Treating and eradicating malaria. Retrieved May 14, 2019, https://www.mmv.org/sites/default/files/uploads/docs/publications/MMV_BusinessPlan_Executive%20Summary.pdf.Google Scholar
• Montibeller G, Belton V (2006) Causal maps and the evaluation of decision options—A review. J. Oper. Res. Soc. 57(7):779–791.Google Scholar
• Montibeller G, Franco A (2010) Multi-criteria decision analysis for strategic decision making. Zopounidis C, Pardalos PM, eds. Handbook of Multicriteria Analysis, Applied Optimization, vol. 103 (Springer, Berlin), 27–48.Google Scholar
• Montibeller G, Winterfeldt D (2015) Cognitive and motivational biases in decision and risk analysis. Risk Anal. 35(7):1230–1251.Google Scholar
• Montibeller G, Gummer H, Tumidei D (2006) Combining scenario planning and multi-criteria decision analysis in practice. J. Multi-Criteria Decision Anal. 14(1–3):5–20.Google Scholar
• Montibeller G, Belton V, Ackermann F, Ensslin L (2008) Reasoning maps for decision aid: An integrated approach for problem-structuring and multi-criteria evaluation. J. Oper. Res. Soc. 59(5):575–589.Google Scholar
• Moon S, Sridhar D, Pate. MA, Jha AK, Clinton C, Delaunay S, Edwin V, et al.. (2015) Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. Lancet 386(10009):2204–2221.Google Scholar
• Mooney G (1987) What does equity in health mean? World Health Statist. Quart. 40(4):296–303.Google Scholar
• Morais DC, Alencar LH, Costa APCS, Keeney RL (2013) Using value-focused thinking in Brazil. Pesquisa Operacional 33(1):73–88.Google Scholar
• Moss K, Michaud J (2013) The U.S. Department of Defense and global health: Infectious disease efforts. Retrieved May 14, 2019, https://www.kff.org/global-health-policy/report/the-u-s-department-of-defense-and-global-health-infectious-disease-efforts/.Google Scholar
• Neumann PJ, Cohen JT (2015) Measuring the value of prescription drugs. New England J. Medicine 373(27):2595–2597.Google Scholar
• Norheim G, Oftung F, Watle S, Wiklund BS, Gouglas D, Schoultz KM, Bakka E, Sommerfelt H, Røttingen JA (2014) Vaccine-based mitigation of the 2014 Ebola viral disease (EVD) epidemic: Gap analysis and proposal for Norwegian initiatives. Report to the Norwegian Ministry of Health, Norwegian Institute of Public Health, Oslo, Norway.Google Scholar
• Nutt P (2002) Making strategic choices. J. Management Stud. 39(1):67–96.Google Scholar
• Orme B (2010) Sample size issues for conjoint analysis. Orme B, ed. Getting Started with Conjoint Analysis: Strategies for Product Design and Pricing Research, 2nd ed. (Research Publishers LLC, Madison, WI), 57–66.Google Scholar
• Osterholm M, Moore K, Ostrowsky J, Kimball-Baker K, Farrar J (2016) The Ebola vaccine team B: A model for promoting the rapid development of medical countermeasures for emerging infectious disease threats. Lancet Infectious Diseases 16(1):e1–e9.Google Scholar
• Pagliusi S, Ting CC, Khomvilai S (2016) Quality vaccines for all people: Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers’ Network, 05–07th October 2015, Bangkok, Thailand. Vaccine 34(31):3562–3567.Google Scholar
• Parnell GS, Conley HW, Jackson JA, Lehmkuhl LJ, Andrew JM (1998) Foundations 2025: A value model for evaluating future air and space forces. Management Sci. 44(10):1336–1350.Link, Google Scholar
• Parnell GS, Hughes DW, Burk RC, Driscoll PJ, Kucik PD, Morales BL, Nunn LR (2013) Invited review—Survey developments and areas for future research. J. Multi-Criteria Decision Anal. 20(1–2):49–60.Google Scholar
• Phillips LD, Bana e Costa CA (2007) Transparent prioritisation, budgeting and resource allocation with multi-criteria decision analysis and decision conferencing. Ann. Oper. Res. 154(1):51–68.Google Scholar
• Plotkin SA, Mahmoud AA, Farrar J (2015) Establishing a global vaccine-development fund. New England J. Medicine 373(4):297–300.Google Scholar
• Porter ME (2010) What is value in healthcare? New England J. Medicine 363(26):2477–2481.Google Scholar
• Program for Appropriate Technology in Health (2018) Center for vaccine innovation and access. Retrieved May 14, 2019, http://sites.path.org/cvia/about-cvia/.Google Scholar
• Punt A (2017) Strategic management decision-making in a complex world: Quantifying, understanding, and using trade-offs. ICES J. Marine Sci. 74(2):499–510.Google Scholar
• Relman DA (2006) Bioterrorism—Preparing to fight the next war. New England J. Medicine 354(2):113–115.Google Scholar
• Reuters (2017) Global coalition aims to outpace epidemics with new vaccines. Retrieved May 14, 2019, https://www.reuters.com/article/us-davos-meeting-vaccines/global-coalition-aims-to-outpace-epidemics-with-new-vaccines-idUSKBN15231Y.Google Scholar
• Rittel H, Webber M (1973) Dilemmas in a general theory of planning. Policy Sci. 4(2):155–159.Google Scholar
• Rodriguez TC, Montibeller G, Oliveira MD, Bana e Costa CA (2017) Modelling multicriteria value interactions with reasoning maps. Eur. J. Oper. Res. 258(3):1054–1071.Google Scholar
• Rosenhead J, Mingers J (2004) Problem structuring methods in action. Eur. J. Oper. Res. 152(3):530–554.Google Scholar
• Røttingen JA, Gouglas D, Feinberg M, Plotkin S, Raghavan KV, Witty A, Draghia-Akli R, Stoffels P, Piot P (2017) New vaccines against epidemic infectious diseases. New England J. Medicine 376(7):610–613.Google Scholar
• Ryan M (2004) Discrete choice experiments in healthcare. BMJ 328(7436):360–361.Google Scholar
• Ryan M, Gerard K, Amaya-Amaya M (2008) Using Discrete Choice Experiments to Value Health and Healthcare (Springer, Dordrecht, Netherlands).Google Scholar
• Saito T, Takeuchi T (2009) Research and development policy on bioterrorism medical countermeasures in the United States. Kansenshogaku Zasshi 83(1):1–6.Google Scholar
• Salo A, Hämäläinen RP (2010) Multicriteria decision analysis in group decision processes. Kilgour D, Eden C, eds. Handbook of Group Decision and Negotiation, Advances in Group Decision and Negotiation, vol. 4 (Springer, Dordrecht, Netherlands).Google Scholar
• Sands P, Mundaca-Shah C, Dzau VJ (2016) The neglected dimension of global security—A framework for countering infectious-disease crises. New England J. Medicine 374(March):1281–1287.Google Scholar
• SAS Institute Inc. (2016) JMP® 13 Consumer Research (SAS Institute Inc., Cary, NC).Google Scholar
• Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, Burroughs H, Jinks C (2018) Saturation in qualitative research: Exploring its conceptualization and operationalization. Quality Quantity 52(4):1893–1907.Google Scholar
• Silkavute P, Tung DX, Jongudomsuk P (2013) Sustaining a regional emerging infectious disease research network: A trust-based approach. Emerging Health Threats J. 6(1):19957.Google Scholar
• Simon J, Regnier E, Whitney L (2014) A value-focused approach to energy transformation in the United States Department of Defense. Decision Anal. 11(2):117–132.Link, Google Scholar
• Smith BT, Inglesby TV, O’Toole T (2003) Biodefense R&D: Anticipating future threats, establishing a strategic environment. Biosecurity Bioterrorism 1(3):193–202.Google Scholar
• Tan JC, Harker PT, Keeney RL (1999) Developing a foundation for strategy at Seagate Software. Interfaces 29(6):4–15.Link, Google Scholar
• Tervonen T, Schmidt-Ott T, Marsh K, Bridges JFP, Quaife M, Janssen E (2018) Assessing rationality in discrete choice experiments in health: An Investigation into the use of dominance tests. Value Health 21(10):1192–1197.Google Scholar
• Thokala P, Devlin N, Marsh K, Baltussen R, Boysen M, Kalo Z, Longgren T, et al.. (2016) Multiple criteria decision analysis for healthcare decision making—An introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health 19(1):1–13.Google Scholar
• Thomas H (1984) Strategic decision analysis: Applied decision analysis and its role in the strategic management process. Strategic Management J. 5(2):139–156.Google Scholar
• Ton K (2015) Global harmonisation in vaccine price. Lancet Infectious Diseases 15(3):249.Google Scholar
• Tully CM, Lambe T, Gilbert SC (2015) Emergency Ebola response: A new approach to the rapid design and development of vaccines against emerging diseases. Lancet Infectious Diseases 15(3):356–359.Google Scholar
• United Nations Secretary General (2016) Protecting humanity from future health crises: Report of the High-level Panel on the Global Response to Health Crises. Report, United Nations, New York.Google Scholar
• U.S. Department of Health and Human Services (2012) An HHS retrospective on the 2009 H1N1 influenza pandemic to advance all hazards preparedness. Retrieved May 14, 2019, https://www.phe.gov/Preparedness/mcm/h1n1-retrospective/Documents/h1n1-retrospective.pdf.Google Scholar
• U.S. Food and Drug Administration (2014) Regulatory pathways for licensure and use of Ebola virus vaccines during the current outbreak FDA perspective. Retrieved May 14, 2019, http://www.who.int/immunization/diseases/ebola/Finn_WHO_Sept_29_2014.pdf.Google Scholar
• Wasserman L (2006) All of Statistics: A Concise Course in Statistical Inference, 2nd ed. (Springer-Verlag, New York).Google Scholar
• Wellcome Trust (2018) Wellcome’s approach to equitable access to healthcare interventions. Retrieved May 14, 2019, https://wellcome.ac.uk/wellcomes-approach-equitable-access-healthcare-interventions.Google Scholar
• Wenstøp F, Myrmel A (2006) Structuring organizational value statements. Retrieved May 14, 2019, http://home.bi.no/fag87027/wenstop/value_structure.pdf.Google Scholar
• World Economic Forum (2015) Managing the risk and impact of future epidemics: Options for public-private cooperation. Retrieved May 14, 2019, http://www3.weforum.org/docs/WEF_Managing_Risk_Epidemics_report_2015.pdf.Google Scholar
• World Health Organization (2010) Strengthening response to pandemics and other public-health emergencies. Report, World Health Organization, Geneva.Google Scholar
• World Health Organization (2015) Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens. Report, World Health Organization, Geneva.Google Scholar
• World Health Organization (2016a) Implementation of the international health regulations (2005): Report of the review committee on the role of the international health regulations (2005) in the Ebola outbreak and response. Retrieved July 11, 2019, http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_21-en.pdf?ua=1.Google Scholar
• World Health Organization (2016b) WHO Ebola R&D effort—Vaccines, therapies, diagnostics. Retrieved May 14, 2019, http://www.who.int/medicines/ebola-treatment/ebola_r_d_effort/en/.Google Scholar
• Yoo SH, Kim JS, Kim TY (2001) Value-focused thinking about strategic management of radio spectrum for mobile communications in Korea. Telecomm. Policy 25(10–11):703–718.Google Scholar